Table 2.
MBL |
Ficolin-1 |
Ficolin-2 |
Ficolin-3 |
|||||
---|---|---|---|---|---|---|---|---|
p | p | p | p | p | p | p | p | |
SAPS II | –0.10 | 0.252 | –0.07 | 0.454 | –0.26 | 0.002 | –0.02 | 0.847 |
SOFA | –0.18 | 0.046 | –0.10 | 0.273 | –0.17 | 0.059 | 0.02 | 0.821 |
LRINEC | –0.08 | 0.395 | 0.12 | 0.181 | 0.09 | 0.329 | 0.08 | 0.376 |
CPa | 0.09 | 0.06 | 0.21 | 0.02 | 0.31 | <0.0001 | 0.45 | <0.0001 |
LPa | 0.12 | 0.18 | 0.24 | 0.007 | 0.47 | <0.0001 | 0.59 | <0.0001 |
APa | 0.33 | <0.0001 | 0.37 | <0.0001 | 0.46 | <0.0001 | 0.40 | <0.0001 |
SAPS II = Simplified Acute Physiology Score II; SOFA = Sepsis-Related Organ Failure Assessment score; LRINEC = Laboratory Risk Indicator for Necrotizing Fasciitis score; CP = classical pathway; LP = ficolin-mediated lectin pathway; AP = alternative pathway.
Baseline complement pathway residual activation capacity.